Cannabics Pharmaceuticals Launches Psilocybin and Psilocin Research Program ...Middle East

PR Newswire - News
Cannabics Pharmaceuticals Launches Psilocybin and Psilocin Research Program
TEL AVIV, Israel and BETHESDA, Md., April 20, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program using Psylocibin and Psilocin. The...

Hence then, the article about cannabics pharmaceuticals launches psilocybin and psilocin research program was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cannabics Pharmaceuticals Launches Psilocybin and Psilocin Research Program )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News